Adagene (ADAG) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Adagene Inc (ADAG) Prix de l'Action, Cotation, Actualités et Historique

ADAGNASDAQ

Trade with Public

Trade with Public

$2.29

0.2311.17%

Dern. MÀJ: Oct 19, 5:01 PM

$2.27

0.2110.19%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

$2.29

Volume / Moy.

4.00 / 286.48K

Fourchette Journalière

- - -

Plage 52 Sem.

1.30 - 4.85

Capitalisation Boursière

$149.98M

Ratio P/E

-

Rendement des Dividendes

-

Échange

NASDAQ

RSI

35

Intérêt à Découvert

3.77%

Jours pour Couvrir

7.47

Actualités Récentes de Adagene Inc.

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Avi Kapoor

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.

Avi Kapoor

Why Is Cancer Focused Adagene Stock Plummeting Today?

Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows limited toxicity, sustained partial responses, and a 22% overall response rate in Colorectal Cancer patients. ADAG shares currently down 47.1% at $2.0."

Vandana Singh

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

-19.25M

Flux de Trésorerie d'Investissement (TTM)

733.40K

Flux de Trésorerie de Financement (TTM)

83.90M

Flux de Trésorerie Libre (TTM)

-19.42M

Dépenses en Capital (TTM)

-170.78K

Variation Nette de la Trésorerie (TTM)

65.39M

Tendances et prévisions des analystes

2

sept.

1

oct.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

4.1

Acheter

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$31.27M

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

12.75

Ratio P/B (TTM)

1.71

Rendement des Bénéfices % (TTM)

-16.45%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

-

Valeur Comptable / Action

$1.33

Dette Entreprise

Dette Totale

$5.73M

Dette à Long Terme

$1.03M

Émission de Dette à Long Terme (TTM)

$5.64M

Remboursement de la Dette à Long Terme (TTM)

-$6.84M

Trésorerie Totale

$127.91M

Dette sur Capitaux Propres

0.07

Émission de Dette (TTM)

-$1.21M

Remboursement de la Dette (TTM)

-$6.84M